Table VI.
Pharmacological treatment of HMB. The number of women who received pharmacological treatment for HMB, the type of treatment they received, and the resulting menstrual bleeding based on clinical measurements.
| Treatment, n | Type of pharmacological treatment, n | |||||||
|---|---|---|---|---|---|---|---|---|
| Clinical menstrual bleeding | Yes | No | LNG-IUS | PCP | DDAVP | TA | VWF/FVIII | Other |
| None (n=8) | 5 | 3a | 4 | 1b | 0 | 0 | 0 | 0 |
| Normal (n=6) | 5 | 1 | 1 | 1 | 4 | 0 | 0 | 1 |
| HMB (n=16) | 14 | 2 | 0 | 2 | 1 | 12 | 2 | 0 |
| Total (n=29)c | 24 | 6 | 5 | 4 | 5 | 12 | 2 | 1 |
a
Reason for no menstruation: Pregnancy or breastfeeding (two cases) and surgery (one case).
b
Continuous treatment with no monthly break.
c
One patient had >1 treatment. HMB, heavy menstrual bleeding; LNG-IUS, levonorgestrel-releasing intrauterine system; PCP, progesterone contraceptive pills; DDAVP, desmopressin D-arginine vasopressin; TA, tranexamic acid; VWF/FVIII, von Willebrand factor/factor VIII concentrates.